TY - JOUR
T1 - Rare solid and cystic presentation of hemangiopericytoma/ solitary fibrous tumor
T2 - A case report
AU - Hayenga, Heather N.
AU - Cai, Chunyu
AU - Fetzer, David
AU - White, Sarah
AU - Kuban, Joshua
AU - Wardak, Zabi
AU - Benjamin, Robert S.
AU - Pan, Edward
AU - Strauss, James
AU - Gao, Boning
AU - Minna, John
AU - Martin-Broto, Javier
AU - Hinshaw, J. Louis
N1 - Publisher Copyright:
© 2022
PY - 2022/6
Y1 - 2022/6
N2 - Hemangiopericytoma/Solitary Fibrous Tumor (HPC/SFT) is a rare fibroblastic sarcoma characterized by hyper-vasculature and STAT6 trans-nuclear localization. Cystic HPC/SFT is extremely rare. Due to the scarcity of cystic HPC/SFT cases, diagnostic and treatment guidelines are not well established. To our knowledge, we present the first case of cystic HPC/SFT observed in the liver. In addition, the patient had over 6 years of recurrent hypervascular solid HPC/SFT in the brain, bone, leptomeninges, liver and lung prior to developing a cystic HPC/SFT. Briefly, a 37-year-old Caucasian female with a history of HPC/SFT presented with several enlarging cystic hepatic lesions on surveillance MRI. The cystic/nonenhancing nature of these liver metastases were confirmed by contrast-enhanced ultrasound. Due to diagnostic uncertainty, two of these hepatic cysts were removed laparoscopically and pathology confirmed cystic HPC/SFT with a high MIB-1 index. Previously, in 2014, the patient was diagnosed with solid intracranial grade III pseudopapillary mesenchymal HPC/SFT in the posterior fossa and underwent subtotal resection followed by external beam radiation. In 2017, she had recurrent intracranial, vertebral, and intraspinal intradural extramedullary HPC/SFTs followed by surgery, proton therapy, and SRS radiotherapy. In 2019, after an uneventful pregnancy and birth, routine surveillance revealed metastases in the liver requiring an extended right hepatectomy. In 2020-2021 two solid hypervascular hepatic HPC/SFT were found and treated with microwave ablation. Shortly afterwards, several rapidly growing hepatic cystic HPC/SFT lesions developed. Of note, she has not taken any systemic therapy, indicating the cystic tumors are from metastases rather than cystic degradation as a sequela of therapy. Overall, this case highlights that cystic metastasis are a potential clinical manifestation of solid HPC/SFT. Moreover, cystic HPC/SFT can co-exist with the more typical primary solid hypervascular HPC/SFTs in the same patient. Lastly, in this case cystic HPC/SFT had a higher growth rate and propensity to metastasize as compared to the solid equivalent.
AB - Hemangiopericytoma/Solitary Fibrous Tumor (HPC/SFT) is a rare fibroblastic sarcoma characterized by hyper-vasculature and STAT6 trans-nuclear localization. Cystic HPC/SFT is extremely rare. Due to the scarcity of cystic HPC/SFT cases, diagnostic and treatment guidelines are not well established. To our knowledge, we present the first case of cystic HPC/SFT observed in the liver. In addition, the patient had over 6 years of recurrent hypervascular solid HPC/SFT in the brain, bone, leptomeninges, liver and lung prior to developing a cystic HPC/SFT. Briefly, a 37-year-old Caucasian female with a history of HPC/SFT presented with several enlarging cystic hepatic lesions on surveillance MRI. The cystic/nonenhancing nature of these liver metastases were confirmed by contrast-enhanced ultrasound. Due to diagnostic uncertainty, two of these hepatic cysts were removed laparoscopically and pathology confirmed cystic HPC/SFT with a high MIB-1 index. Previously, in 2014, the patient was diagnosed with solid intracranial grade III pseudopapillary mesenchymal HPC/SFT in the posterior fossa and underwent subtotal resection followed by external beam radiation. In 2017, she had recurrent intracranial, vertebral, and intraspinal intradural extramedullary HPC/SFTs followed by surgery, proton therapy, and SRS radiotherapy. In 2019, after an uneventful pregnancy and birth, routine surveillance revealed metastases in the liver requiring an extended right hepatectomy. In 2020-2021 two solid hypervascular hepatic HPC/SFT were found and treated with microwave ablation. Shortly afterwards, several rapidly growing hepatic cystic HPC/SFT lesions developed. Of note, she has not taken any systemic therapy, indicating the cystic tumors are from metastases rather than cystic degradation as a sequela of therapy. Overall, this case highlights that cystic metastasis are a potential clinical manifestation of solid HPC/SFT. Moreover, cystic HPC/SFT can co-exist with the more typical primary solid hypervascular HPC/SFTs in the same patient. Lastly, in this case cystic HPC/SFT had a higher growth rate and propensity to metastasize as compared to the solid equivalent.
KW - Brain
KW - Cyst
KW - Hemangiopericytoma
KW - Intradural
KW - Liver
KW - Lung
KW - Metastasis
KW - Solitary fibrous tumor
KW - Spine
UR - http://www.scopus.com/inward/record.url?scp=85133151911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133151911&partnerID=8YFLogxK
U2 - 10.1016/j.cpccr.2022.100149
DO - 10.1016/j.cpccr.2022.100149
M3 - Article
AN - SCOPUS:85133151911
SN - 2666-6219
VL - 6
JO - Current Problems in Cancer: Case Reports
JF - Current Problems in Cancer: Case Reports
M1 - 100149
ER -